1. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
    Jiabei Zhou et al, 2020, Frontiers in Pharmacology CrossRef
  2. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway
    Jing Chen et al, 2024, Critical Reviews in Immunology CrossRef
  3. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
    Shun-Zhen Zheng et al, 2019, World Journal of Gastroenterology CrossRef
  4. Research Progress on Platinum Resistance Mechanism and Resistance Therapy in Retinoblastoma
    应洁 罗, 2024, Advances in Clinical Medicine CrossRef
  5. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
    Nasrin Ahangar Davoodi et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  6. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression
    Xiulan Lu et al, 2022, Current Eye Research CrossRef

  7. Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells


    Xiang Wen Yuan et al, 2020, Cancer Management and Research CrossRef